arrow
C

Christina H. Ruhlmann

Odense University Hospital
H指数:15
被引数:1,250

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early discontinuation of immune checkpoint inhibitors after objective response in real-world melanoma: clinical and economic impact

黑色素瘤真实世界中客观缓解后免疫检查点抑制剂的早期停药:临床和经济影响

2026-10-220
OA
Progression risk among responders to PD-1/PD-L1 blockade is primarily stratified by response depth: a nationwide cohort study of 2,127 patients with melanoma, RCC, and NSCLC

对PD-1/PD-L1阻断治疗的应答者中进展风险主要由应答深度分层:一项涉及2,127例黑素瘤、肾细胞癌和非小细胞肺癌患者的大型队列研究

2026-06-050
OAAI
Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score-matched survival analysis

达拉非尼联合曲美替尼与恩考拉非尼联合比美替尼在BRAF突变型转移性黑色素瘤中的比较:一项真实世界倾向性评分匹配的生存分析

2025-10-010
PRE
Promoting a research agenda for cancer treatment for intravenous devices with clinicians in Europe; the PRACTICE survey

推动欧洲临床医生对静脉输液装置癌症治疗的研究议程;PRACTICE调查

2025-09-010
PRE
Safety and antiemetic efficacy of weekly administration of netupitant/palonosetron plus dexamethasone during 5 weeks of concomitant chemo-radiotherapy-the DANGER-emesis study

奈妥匹坦/帕洛诺司琼联合地塞米松每周给药在5周同步放化疗期间的安全性及止吐疗效——DANGER-EMESIS研究

2025-05-280
OA
Immune-related adverse events in a nationwide cohort of real-world melanoma patients treated with adjuvant anti-PD1-Seasonal variation and association with outcome

在全国范围内接受辅助anti-PD1-Seasonal变异治疗的真实世界黑色素瘤患者队列中与免疫相关的不良事件及其与结果的关联

2024-11-010
OAAI
Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care-an international Delphi study

支持性护理2030运动: 统一全球卓越癌症支持性护理的雄心-一项国际德尔菲研究

2024-10-011
OAAI
2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
2024-02-0124
OAAI